151 related articles for article (PubMed ID: 19015346)
1. Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
Hynninen VV; Olkkola KT; Bertilsson L; Kurkinen KJ; Korhonen T; Neuvonen PJ; Laine K
Antimicrob Agents Chemother; 2009 Feb; 53(2):587-92. PubMed ID: 19015346
[TBL] [Abstract][Full Text] [Related]
2. Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Vyyryläinen H; Laine K
Antimicrob Agents Chemother; 2006 Jun; 50(6):1967-72. PubMed ID: 16723553
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole and fluconazole increase the exposure to oral diazepam.
Saari TI; Laine K; Bertilsson L; Neuvonen PJ; Olkkola KT
Eur J Clin Pharmacol; 2007 Oct; 63(10):941-9. PubMed ID: 17676319
[TBL] [Abstract][Full Text] [Related]
4. Effect of voriconazole on the pharmacokinetics of diclofenac.
Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Laine K
Fundam Clin Pharmacol; 2007 Dec; 21(6):651-6. PubMed ID: 18034666
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
Karonen T; Laitila J; Niemi M; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2012 May; 68(5):681-8. PubMed ID: 22108774
[TBL] [Abstract][Full Text] [Related]
6. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Br J Clin Pharmacol; 2007 Jan; 63(1):116-20. PubMed ID: 16822278
[TBL] [Abstract][Full Text] [Related]
7. Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam.
Bae JW; Choi CI; Jang CG; Lee SY
Br J Clin Pharmacol; 2011 Apr; 71(4):550-5. PubMed ID: 21395648
[TBL] [Abstract][Full Text] [Related]
8. [Drug-drug interaction of antifungal drugs].
Niwa T; Shiraga T; Takagi A
Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole increases plasma concentrations of quinidine.
Kaukonen KM; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
[TBL] [Abstract][Full Text] [Related]
11. Voriconazole drastically increases exposure to oral oxycodone.
Hagelberg NM; Nieminen TH; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Eur J Clin Pharmacol; 2009 Mar; 65(3):263-71. PubMed ID: 18836708
[TBL] [Abstract][Full Text] [Related]
12. Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam.
Türck D; Heinzel G; Luik G
Br J Clin Pharmacol; 2000 Sep; 50(3):197-204. PubMed ID: 10971303
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
Fihlman M; Hemmilä T; Hagelberg NM; Kuusniemi K; Backman JT; Laitila J; Laine K; Neuvonen PJ; Olkkola KT; Saari TI
Eur J Clin Pharmacol; 2016 Nov; 72(11):1363-1371. PubMed ID: 27510521
[TBL] [Abstract][Full Text] [Related]
14. Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.
Hynninen VV; Olkkola KT; Neuvonen PJ; Laine K
Eur J Clin Pharmacol; 2009 Jan; 65(1):89-95. PubMed ID: 18777173
[TBL] [Abstract][Full Text] [Related]
15. Effects of itraconazole and tandospirone on the pharmacokinetics of perospirone.
Masui T; Kusumi I; Takahashi Y; Koyama T
Ther Drug Monit; 2006 Feb; 28(1):73-5. PubMed ID: 16418697
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
Verweij PE; Mensink M; Rijs AJ; Donnelly JP; Meis JF; Denning DW
J Antimicrob Chemother; 1998 Sep; 42(3):389-92. PubMed ID: 9786480
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of meloxicam after intravenous, intramuscular, and oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis).
Molter CM; Court MH; Cole GA; Gagnon DJ; Hazarika S; Paul-Murphy JR
Am J Vet Res; 2013 Mar; 74(3):375-80. PubMed ID: 23438111
[TBL] [Abstract][Full Text] [Related]
18. Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
Yamazaki H; Nakamoto M; Shimizu M; Murayama N; Niwa T
Br J Clin Pharmacol; 2010 Jun; 69(6):593-7. PubMed ID: 20565450
[TBL] [Abstract][Full Text] [Related]
19. Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use.
Blain H; Boileau C; Lapicque F; Nédélec E; Loeuille D; Guillaume C; Gaucher A; Jeandel C; Netter P; Jouzeau JY
Br J Clin Pharmacol; 2002 Mar; 53(3):255-65. PubMed ID: 11874389
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
Kaukonen KM; Olkkola KT; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
